Compare OBK & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBK | ARDX |
|---|---|---|
| Founded | 1912 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2018 | 2014 |
| Metric | OBK | ARDX |
|---|---|---|
| Price | $49.11 | $5.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $46.67 | $15.14 |
| AVG Volume (30 Days) | 105.2K | ★ 2.9M |
| Earning Date | 04-22-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.13% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.89 | N/A |
| Revenue | N/A | ★ $2,607,000.00 |
| Revenue This Year | $26.43 | $37.75 |
| Revenue Next Year | $5.79 | $34.24 |
| P/E Ratio | $54.84 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $32.13 | $3.54 |
| 52 Week High | $49.50 | $8.40 |
| Indicator | OBK | ARDX |
|---|---|---|
| Relative Strength Index (RSI) | 63.39 | 39.84 |
| Support Level | $46.28 | $5.46 |
| Resistance Level | N/A | $6.23 |
| Average True Range (ATR) | 0.94 | 0.25 |
| MACD | 0.11 | -0.05 |
| Stochastic Oscillator | 87.74 | 28.76 |
Origin Bancorp Inc is a financial holding company that provides personalized, relationship banking to businesses, municipalities, and personal clients in the communities it serves. The company offers a broad range of financial services and operates more than 56 locations in Dallas/Fort Worth, East Texas, Houston, North Louisiana, Mississippi, South Alabama, and the Florida Panhandle. It also provides insurance agency products and services through its wholly owned insurance agency subsidiary. The company operates in one business segment, community banking, and is mainly engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.